Comparative Clinical Pharmacokinetics of Tacrolimus in Paediatric and Adult Patients
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (4) , 283-295
- https://doi.org/10.2165/00003088-200140040-00004
Abstract
Tacrolimus is a potent immunosuppressive agent used to prevent allograft rejection. The pharmacokinetics of tacrolimus have been studied in healthy volunteers and transplant recipients, mostly by...Keywords
This publication has 108 references indexed in Scilit:
- Cytochrome P450 3AClinical Pharmacokinetics, 1999
- TacrolimusDrugs, 1997
- A Simplified Whole Blood Enzyme-linked Immunosorbent Assay (ProTrac II) for Tacrolimus (FK506) Using Proteolytic Extraction in Place of Organic SolventsTherapeutic Drug Monitoring, 1996
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Clinical use of tacrolimus (FK-506) in infants and children with renal transplantsPediatric Nephrology, 1995
- Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patientsTransplant International, 1994
- Pharmacokinetics of FK506 After Intravenous and Oral Administration in Patients Awaiting Renal TransplantationThe Journal of Clinical Pharmacology, 1994
- FK 506 interaction with danazolThe Lancet, 1993
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationNature, 1992
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989